Items Tagged with 'Pfizer'


Drug maker creating 450 jobs

July 24, 2018
A drug maker is planning to build a new $465-million plant in the region that will create 450 jobs. Read More

Drug maker opens $30M warehouse

February 21, 2018
A global drug maker with a manufacturing operation in the region has opened a 98,500-square-foot warehouse to free up production space on its campus. Read More

Drug maker hiring 400 workers

November 14, 2017
A drug maker is in the process of hiring more than 400 workers for its manufacturing operation in the region. Read More

Drug maker plans $146M expansion

September 7, 2016
A New York-based drug maker is preparing to start a $146-million construction project to expand its presence in the region. Read More

Tax footnote of financial statements reveal important information

March 4, 2016
The last week of February, a news report said Pfizer reportedly would save $35 billion in taxes by virtue of its announced plans to merge with Allergan. Read More

Pfizer's new arthritis drug promises relief . . . to Pfizer

Sales of Xeljanz will offset losses due to expiring patents such as Lipitor.

November 14, 2012
The new rheumatoid arthritis drug from Pfizer — Xeljanz — which has just been approved by the Food and Drug Administration, is predicted to yield sales of more than $2 billion a year in a few years. That good news for Pfizer, however, is offset by the fact Pfizer is facing near-term challenges due to expiring patents, resulting in new competition from generic drugs. Read More

Pfizer to acquire NextWave Pharmaceuticals

NextWave makes the new ADHD drug Quillivant XR.

November 1, 2012
Global pharmaceutical maker Pfizer has announced its intention to acquire NextWave Pharmaceuticals of Cupertino, Calif., developer of Quillivant XR, the first once-daily liquid medication approved in the U.S. for the treatment of ADHD. Quillivant XR received approval from the U.S. Food and Drug Administration on Sept. 27, and it is expected to be in U.S. pharmacies in January. Read More